generics

Pfizer responds to FDA, EMA and Canada after reinspections of plant that makes injected painkillers
Pfizer responds to FDA, EMA and Canada after reinspections of plant that makes injected painkillers
Fierce Pharma
Pfizer
generics
painkillers
FDA
EMA
Canada
injectables
drug manufacturing
Flag link:
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
EpiPens
generics
Teva Pharmaceutical
Mylan
allergic reaction
Flag link:
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Fierce Pharma
Teva Pharmaceutical
Copaxone
Azilect
kickbacks
generics
whistleblowers
Flag link:
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Gilead loses key patent claims for Sovaldi in China, opening door to earlier generic entry
Endpoints
China
Gilead Sciences
hepatitis C
generics
Sovaldi
Flag link:
Biosimilars and Complex Generics Uptake Not as Expected – Why is that a Surprise?
Biosimilars and Complex Generics Uptake Not as Expected – Why is that a Surprise?
Lachman Consultants
biosimilars
Hatch Waxman Act
generics
Flag link:
Mylan Launches First Adcirca Generic, Stock Moves Up
Mylan Launches First Adcirca Generic, Stock Moves Up
Market Realist
Mylan
tadalafil
generics
PAH
Adcirca
United Therapeutics
Flag link:
Express Scripts Cuts 48 Drugs from 2019 Formulary
Express Scripts Cuts 48 Drugs from 2019 Formulary
Pharma Voice
Express Scripts
PBMs
formulary
generics
Flag link:
Generic Drugmakers Struggle Despite U.S. Push for Copycats
Generic Drugmakers Struggle Despite U.S. Push for Copycats
Yahoo/Bloomberg
generics
Donald Trump
drug pricing
Flag link:
July Marks All-Time High in FDA Generic Drug Approvals
July Marks All-Time High in FDA Generic Drug Approvals
RAPS.org
FDA
drug approvals
generics
Flag link:
Humana sues drugmakers alleging generic price-fixing scheme
Humana sues drugmakers alleging generic price-fixing scheme
Biopharma Dive
antitrust
Humana
price collusion
generics
Flag link:
It Feels Like the First Time: FDA’s First Competitive Generic Therapy Approval
It Feels Like the First Time: FDA’s First Competitive Generic Therapy Approval
FDA Law Blog
FDA
generics
Flag link:
CVS sues Pfizer over decade-old Lipitor generics deal, aiming to recoup some cash
CVS sues Pfizer over decade-old Lipitor generics deal, aiming to recoup some cash
Fierce Pharma
Pfizer
CVS Health
generics
Lipitor
competition
pay-for-delay
Flag link:
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Clover BioPharmaceuticals
SCB-808
Enbrel
generics
Flag link:
Viagra Clinical Trial of Pregnant Women Ends After 11 Babies Die as a Result of Lung Problems
Viagra Clinical Trial of Pregnant Women Ends After 11 Babies Die as a Result of Lung Problems
Xtalks
clinical trials
Viagra
pregnancy
drug safety
generics
Flag link:
Regulators recall valsartan after finding impurity tied to cancer risk
Regulators recall valsartan after finding impurity tied to cancer risk
Biopharma Dive
FDA
EMA
recalls
generics
Valsartan
Flag link:
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States
Drug Patent Watch
Pfizer
Viagra
generics
Flag link:
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Flag link:
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Fierce Pharma
Mylan Labs
Copaxone
generics
Teva Pharmaceuticals
MS
drug pricing
Flag link:
U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
Reuters
Jazz Pharmaceuticals
narcolepsy
Xyrem
Amneal
generics
Flag link:
Generic Approvals Rebound as First Generics Don’t Keep Pace With 2016 or 2017
Generic Approvals Rebound as First Generics Don’t Keep Pace With 2016 or 2017
RAPS.org
generics
drug approvals
Flag link:

Pages